Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

November 21, 2022

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

News Conference News AHA 2022

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

November 05, 2022

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

October 24, 2022

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

October 20, 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

September 18, 2022

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups

News Daily News

Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups

August 23, 2022

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

News Daily News

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Michael O'Riordan

July 27, 2022

SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization

News Conference News ACC 2022

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

April 02, 2022

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

COVID-19: TCTMD’s Dispatch for March Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 4

March 21, 2022

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

March 02, 2022

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.